Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio

Head and Neck

Volumn 38, Issue , 2016, Pages E1332-E1340

  Hu, Guoqing ^a   Sun, Wei ^a   Zhang, Linli ^a   Luo, Min ^a   Hu, Guangyuan ^a   Mei, Qi ^a   Liu, Dongbo ^a   Long, Guoxian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

hematologic markers; nasopharyngeal carcinoma; neutrophil lymphocyte ratio; platelet lymphocyte ratio; prognosis

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; FEMALE; FOLLOW UP; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NASOPHARYNX CARCINOMA; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHYSICAL EXAMINATION; PLATELET LYMPHOCYTE RATIO; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; TREATMENT DURATION; BLOOD CELL COUNT; CARCINOMA; CYTOLOGY; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LYMPHOCYTE; NASOPHARYNX TUMOR; NEUTROPHIL; PROGNOSIS; THROMBOCYTE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD CELL COUNT; BLOOD PLATELETS; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84941595608     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.24224     Document Type: Article

References (41)

1. Chan AT., Nasopharyngeal carcinoma. Ann Oncol 2010; 21 Suppl 7: vii308-vii312.
2. Sun R, Qiu HZ, Mai HQ, et al., Prognostic value and differences of the sixth and seventh editions of the UICC/AJCC staging systems in nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2013; 139: 307-314.
3. Xu J, Wan XB, Huang XF, et al., Serologic antienzyme rate of Epstein-Barr virus DNase-specific neutralizing antibody segregates TNM classification in nasopharyngeal carcinoma. J Clin Oncol 2010; 28: 5202-5209.
4. Wang HY, Sun BY, Zhu ZH, et al., Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival. J Clin Oncol 2011; 29: 4516-4525.
5. Lin JC, Wang WY, Chen KY, et al., Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004; 350: 2461-2470.
6. Liu N, Chen NY, Cui RX, et al., Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol 2012; 13: 633-641.
7. Sun W, Long G, Wang J, Mei Q, Liu D, Hu G., Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: a meta-analysis. Head Neck 2014; 36: 1508-1516.
8. Le QT, Zhang Q, Cao H, et al., An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma. Clin Cancer Res 2013; 19: 2208-2215.
9. Grivennikov SI, Greten FR, Karin M., Immunity, inflammation, and cancer. Cell 2010; 140: 883-899.
10. Pei D, Zhu F, Chen X, et al., Pre-adjuvant chemotherapy leukocyte count may predict the outcome for advanced gastric cancer after radical resection. Biomed Pharmacother 2014; 68: 213-217.
11. Tsai YD, Wang CP, Chen CY, et al., Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck 2014; 36: 947-953.
12. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K., Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br J Cancer 2013; 109: 401-407.
13. Rachidi S, Wallace K, Day TA, Alberg AJ, Li Z., Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma. J Hematol Oncol 2014; 7: 65.
14. Absenger G, Szkandera J, Pichler M, et al., A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Br J Cancer 2013; 109: 395-400.
15. Pichler M, Hutterer GC, Stoeckigt C, et al., Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer 2013; 108: 901-907.
16. Stotz M, Gerger A, Eisner F, et al., Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 2013; 109: 416-421.
17. Pinato DJ, Shiner RJ, Seckl MJ, Stebbing J, Sharma R, Mauri FA., Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Br J Cancer 2014; 110: 1930-1935.
18. Krenn-Pilko S, Langsenlehner U, Thurner EM, et al., The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer 2014; 110: 2524-2530.
19. Racz JM, Cleghorn MC, Jimenez MC, et al., Predictive ability of blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in gastrointestinal stromal tumors. Ann Surg Oncol 2015; 22: 2343-2350.
20. Cannon NA, Meyer J, Iyengar P, et al., Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer. J Thorac Oncol 2015; 10: 280-285.
21. An X, Ding PR, Wang FH, Jiang WQ, Li YH., Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biol 2011; 32: 317-324.
22. He JR, Shen GP, Ren ZF, et al., Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck 2012; 34: 1769-1776.
23. Chang H, Gao J, Xu BQ, et al., Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution. Clin Oncol (R Coll Radiol) 2013; 25: 639-646.
24. Jin Y, Ye X, He C, Zhang B, Zhang Y., Pretreatment neutrophil-to-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma. Head Neck 2015; 37: 69-75.
25. Rassouli A, Saliba J, Castano R, Hier M, Zeitouni AG., Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Head Neck 2015; 37: 103-110.
26. Rachidi S, Wallace K, Wrangle JM, Day TA, Alberg AJ, Li Z., Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck 2015. [Epub ahead of print]
27. Tecchio C, Scapini P, Pizzolo G, Cassatella MA., On the cytokines produced by human neutrophils in tumors. Semin Cancer Biol 2013; 23: 159-170.
28. Webb NJ, Myers CR, Watson CJ, Bottomley MJ, Brenchley PE., Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine 1998; 10: 254-257.
29. Neagoe PE, Brkovic A, Hajjar F, Sirois MG., Expression and release of angiopoietin-1 from human neutrophils: intracellular mechanisms. Growth Factors 2009; 27: 335-344.
30. Tecchio C, Cassatella MA., Neutrophil-derived cytokines involved in physiological and pathological angiogenesis. Chem Immunol Allergy 2014; 99: 123-137.
31. Basso S, Zecca M, Merli P, et al., T cell therapy for nasopharyngeal carcinoma. J Cancer 2011; 2: 341-346.
32. Duong CP, Yong CS, Kershaw MH, Slaney CY, Darcy PK., Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic. Mol Immunol 2015. [Epub ahead of print]
33. Sharma D, Brummel-Ziedins KE, Bouchard BA, Holmes CE., Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer. J Cell Physiol 2014; 229: 1005-1015.
34. Gakis G, Fritsche HM, Hassan F, et al., Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy. Eur J Cancer 2014; 50: 2583-2591.
35. Chen YP, Chen C, Mai ZY, et al., Pretreatment platelet count as a predictor for survival and distant metastasis in nasopharyngeal carcinoma patients. Oncol Lett 2015; 9: 1458-1466.
36. Balta S, Demirkol S, Unlu M, Arslan Z, Celik T., Neutrophil to lymphocyte ratio may be predict of mortality in all conditions. Br J Cancer 2013; 109: 3125-3126.
37. Stotz M, Szkandera J, Stojakovic T, et al., The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer. Clin Chem Lab Med 2015; 53: 499-506.
38. Stotz M, Pichler M, Absenger G, et al., The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer 2014; 110: 435-440.
39. Szkandera J1, Gerger A, Liegl-Atzwanger B, et al., The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas. Int J Cancer 2014; 135: 362-370.
40. Thurner EM, Krenn-Pilko S, Langsenlehner U, et al., The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy. Eur J Cancer 2015; 51: 610-619.
41. Szkandera J, Stotz M, Absenger G, et al., Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients. Br J Cancer 2014; 110: 183-188.